Hemochromatosis: genetics and pathophysiology
- PMID: 16409153
- DOI: 10.1146/annurev.med.57.121304.131310
Hemochromatosis: genetics and pathophysiology
Abstract
A number of genetic disorders can result in the accumulation of excess iron in the body. These causes of hereditary hemochromatosis include defects in genes encoding HFE, transferrin receptor 2, ferroportin, hepcidin, and hemojuvelin. Hepcidin, with its cognate receptor, ferroportin, has emerged as a central regulator of iron homeostasis; all of the known causes of hemochromatosis appear to prevent this system from functioning normally. The most common form of primary hemochromatosis is that caused by C282Y mutation of the HFE gene. This mutation is most prevalent among Northern Europeans. Although the frequency of the homozygous genotype is approximately 5 per 1000, the disease itself is quite rare because the clinical penetrance of the genotype is very low.
Similar articles
-
[Pathophysiology and genetics of classic HFE (type 1) hemochromatosis].Presse Med. 2007 Sep;36(9 Pt 2):1271-7. doi: 10.1016/j.lpm.2007.03.038. Epub 2007 May 22. Presse Med. 2007. PMID: 17521857 Review. French.
-
[Non-HFE-related hereditary iron overload].Presse Med. 2007 Sep;36(9 Pt 2):1279-91. doi: 10.1016/j.lpm.2007.01.042. Epub 2007 May 30. Presse Med. 2007. PMID: 17540536 Review. French.
-
New insights into iron homeostasis through the study of non-HFE hereditary haemochromatosis.Best Pract Res Clin Haematol. 2005 Jun;18(2):235-50. doi: 10.1016/j.beha.2004.09.004. Best Pract Res Clin Haematol. 2005. PMID: 15737887 Review.
-
Non-HFE hemochromatosis.Semin Liver Dis. 2005 Nov;25(4):450-60. doi: 10.1055/s-2005-923316. Semin Liver Dis. 2005. PMID: 16315138 Review.
-
Genetics, Genetic Testing, and Management of Hemochromatosis: 15 Years Since Hepcidin.Gastroenterology. 2015 Oct;149(5):1240-1251.e4. doi: 10.1053/j.gastro.2015.06.045. Epub 2015 Jul 9. Gastroenterology. 2015. PMID: 26164493 Review.
Cited by
-
HFE gene mutation and oxidative damage biomarkers in patients with myelodysplastic syndromes and its relation to transfusional iron overload: an observational cross-sectional study.BMJ Open. 2015 Apr 3;5(4):e006048. doi: 10.1136/bmjopen-2014-006048. BMJ Open. 2015. PMID: 25841232 Free PMC article.
-
Iron overload and cofactors with special reference to alcohol, hepatitis C virus infection and steatosis/insulin resistance.World J Gastroenterol. 2007 Sep 21;13(35):4699-706. doi: 10.3748/wjg.v13.i35.4699. World J Gastroenterol. 2007. PMID: 17729391 Free PMC article. Review.
-
The oral iron chelator deferiprone protects against systemic iron overload-induced retinal degeneration in hepcidin knockout mice.Invest Ophthalmol Vis Sci. 2014 Jun 26;55(7):4525-32. doi: 10.1167/iovs.14-14568. Invest Ophthalmol Vis Sci. 2014. PMID: 24970260 Free PMC article.
-
The flatiron mutation in mouse ferroportin acts as a dominant negative to cause ferroportin disease.Blood. 2007 May 15;109(10):4174-80. doi: 10.1182/blood-2007-01-066068. Epub 2007 Feb 8. Blood. 2007. PMID: 17289807 Free PMC article.
-
Engineering Peptide Inhibitors of the HFE-Transferrin Receptor 1 Complex.Molecules. 2022 Oct 4;27(19):6581. doi: 10.3390/molecules27196581. Molecules. 2022. PMID: 36235117 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical